Carbonic Anhydrase IX-Targeted α-Radionuclide Therapy with 225Ac Inhibits Tumor Growth in a Renal Cell Carcinoma Model by Merkx, Robin I J, Rijpkema, Mark, Franssen, Gerben M, Kip, Annemarie, Smeets, Bart, Morgenstern, Alfred, Bruchertseifer, Frank, Yan, Eddie, Wheatcroft, Michael P, Oosterwijk, Egbert, Mulders, Peter F A, Heskamp, Sandra

Get full text

Phase I study to assess safety, biodistribution and radiation dosimetry for 89Zr-girentuximab in patients with renal cell carcinoma by Merkx, Robin I. J., Lobeek, Daphne, Konijnenberg, Mark, Jiménez-Franco, Luis David, Kluge, Andreas, Oosterwijk, Egbert, Mulders, Peter F.A., Rijpkema, Mark

Get full text

Phase I study to assess safety, biodistribution and radiation dosimetry for 89 Zr-girentuximab in patients with renal cell carcinoma by Merkx, Robin I J, Lobeek, Daphne, Konijnenberg, Mark, Jiménez-Franco, Luis David, Kluge, Andreas, Oosterwijk, Egbert, Mulders, Peter F A, Rijpkema, Mark

Get full text

Validation of 3D documentation of palatal soft tissue shape, color, and irregularity with intraoral scanning by Deferm, Julie T., Schreurs, Ruud, Baan, Frank, Bruggink, Robin, Merkx, Matthijs A. W., Xi, Tong, Bergé, Stefaan J., Maal, Thomas J. J.

Get full text

A Generic Antibody-Blocking Protein That Enables pH-Switchable Activation of Antibody Activity by Biewenga, Lieuwe, Vermathen, Robin, Rosier, Bas J.H.M., Merkx, Maarten

Get full text

Mapping Antibody Domain Exposure on Nanoparticle Surfaces Using DNA-PAINT by Tholen, Marrit M. E., Rosier, Bas J. H. M., Vermathen, Robin T., Sewnath, Céline A. N., Storm, Cornelis, Woythe, Laura, Izquierdo-Lozano, Cristina, Riera, Roger, van Egmond, Marjolein, Merkx, Maarten, Albertazzi, Lorenzo

Get full text

Integrated Bioluminescent Immunoassays for High-Throughput Sampling and Continuous Monitoring of Cytokines by van Aalen, Eva A., Rosier, Bas J. H. M., Jansen, Tom, Wouters, Simone F. A., Vermathen, Robin T., van der Veer, Harmen J., Yeste Lozano, José, Mughal, Sheeza, Fernández-Costa, Juan M., Ramón-Azcón, Javier, den Toonder, Jaap M. J., Merkx, Maarten

Get full text

89ZrZr-girentuximab for PET-CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial by Shuch, Brian, Pantuck, Allan J, Bernhard, Jean-Christophe, Morris, Michael A, Master, Viraj, Scott, Andrew M, van Praet, Charles, Bailly, Clement, Önal, Bülent, Aksoy, Tamer, Merkx, Robin, Schuster, David M, Lee, Sze Ting, Pandit-Taskar, Neeta, Fan, Alice C, Allman, Phillip, Schmidt, Karl, Tauchmanova, Libuse, Wheatcroft, Michael, Behrenbruch, Christian, Hayward, Colin R W, Mulders, Peter

Get full text

[89Zr]Zr-girentuximab for PET–CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial by Shuch, Brian, Pantuck, Allan J, Bernhard, Jean-Christophe, Morris, Michael A, Master, Viraj, Scott, Andrew M, van Praet, Charles, Bailly, Clement, Önal, Bülent, Aksoy, Tamer, Merkx, Robin, Schuster, David M, Lee, Sze Ting, Pandit-Taskar, Neeta, Fan, Alice C, Allman, Phillip, Schmidt, Karl, Tauchmanova, Libuse, Wheatcroft, Michael, Behrenbruch, Christian, Hayward, Colin R W, Mulders, Peter

Get full text